Home / News & media website / News / Postpartum Depression Pill Approved In The US


The United States Food and Drug Administration (FDA) has approved medication for the treatment of postpartum depression.

This type of depression is a very serious mental illness. It develops after childbirth and affects about 1 in 7 women.

The FDA said the medication will be sold under the brand name Zurzuvae. It will be prescribed to be taken once a day for 14 days straight.

Dr. Tiffany Farchione of the FDA said postpartum depression not only affects mothers, but their children as well.

“Postpartum depression is a serious and potentially life-threatening condition in which women experience sadness, guilt, worthlessness – even, in severe cases, thoughts of harming themselves or their child.”

The chance to access the medicine “will be a beneficial option for many of these women coping with extreme, and sometimes life-threatening, feelings”.

CNN reports that with severe postpartum depression, women are unable to function with daily routines and often have recurring thoughts of suicide, self-harm or harming the baby, which are very serious symptoms that require immediate evaluation and attention.

Image credit: MarketWatch

Rhodes Offers Free Holiday For Tourists Who Fled Fires
Mattel Advertises For Chief Uno Player Position
Man Visits Every Country Without Flying
Canadian PM Announces Separation From Wife
‘Fake Bear’ Attracts 20,000 Visitors a Day After Going Viral
Iran Declares Two-Day Holiday Due To Heat
Dame Judi Dench Reveals Degenerative Eye Condition
Daredevil Stuntman Found Dead After Stunt Gone Wrong
World’s Biggest Office Block Opens